158
Participants
Start Date
April 30, 2016
Primary Completion Date
November 30, 2017
Study Completion Date
March 31, 2018
CKD-390
CKD-390 1 Tablet (48 weeks)
viread
viread1 Tablet (24 weeks), CKD-390 1 Tablet (from 24 weeks to 48 weeks)
NOT_YET_RECRUITING
Korea University Ansan Hospital, Ansan
NOT_YET_RECRUITING
Bundang Cha Medical Center, Bundang
RECRUITING
Hanyang University Guri Hospital, Guri-si
RECRUITING
Inje University Ilsan Paik Hospital, Ilsan
ACTIVE_NOT_RECRUITING
Gachon University of Medicine and Science Gil Medical Center, Incheon
ACTIVE_NOT_RECRUITING
Ajou University Hospital, Suwon
ACTIVE_NOT_RECRUITING
Busan National University Hospital, Busan
ACTIVE_NOT_RECRUITING
Keimyung University Dongsan Medical Center, Daegu
NOT_YET_RECRUITING
Yeungnam University Medical Center, Daegu
NOT_YET_RECRUITING
Chungnam National University Hospital, Daejeon
NOT_YET_RECRUITING
Jeju National University Hospital, Jeju City
ACTIVE_NOT_RECRUITING
Chungang University Hospital, Seoul
ACTIVE_NOT_RECRUITING
Hanyang University Hospital, Seoul
NOT_YET_RECRUITING
Kangnam Severance Hospital, Seoul
NOT_YET_RECRUITING
Korea University Guro Hosptial, Seoul
ACTIVE_NOT_RECRUITING
Samsung Medical Center, Seoul
ACTIVE_NOT_RECRUITING
Seoul Asan Medical Center, Seoul
ACTIVE_NOT_RECRUITING
Seoul National University Hospital, Seoul
ACTIVE_NOT_RECRUITING
Seoul Saint Mary's Hospital, Seoul
NOT_YET_RECRUITING
Severance Hospital, Seoul
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY